Walethmade%2525252525252520bromide

# Walethmade bromide ## Overview **Note:** "Walethmade bromide" is not a recognized pharmaceutical agent. It is likely a misspelling of **Aclidinium bromide** (a long-acting muscarinic antagonist) or a confusion with another anticholinergic agent. Please cross-reference the prescribing name, as administering an unknown compound is dangerous. Assuming clinical intent regarding long-acting anticholinergics (e.g., Aclidinium): ## Primary Indications Maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. ## Adult Dosing If referring to Aclidinium bromide (Inhalation powder): 400 mcg twice daily. ## Pediatric Dosing Not indicated for use in pediatric patients. Safety and efficacy have not been established. ## Dose Adjustments No specific dosage adjustments are required based on age or mild-to-moderate renal or hepatic impairment. ## Contraindications Hypersensitivity to aclidinium bromide, atropine, or its derivatives. ## Adverse Effects Common: Headache, nasopharyngitis, cough. Serious: Paradoxical bronchospasm, anticholinergic effects (urinary retention, narrow-angle glaucoma, dry mouth, blurred vision). ## Key Drug Interactions Avoid concomitant use with other anticholinergic medications (e.g., tiotropium, ipratropium) due to potential additive toxicity. ## Monitoring Monitor for signs of paradoxical bronchospasm upon administration. Monitor for worsening of urinary retention or ocular symptoms (blurred vision/halos) in susceptible individuals. ## Clinical Pearls This medication is for maintenance therapy only and is **not** to be used as a rescue inhaler for acute episodes of bronchospasm. Patients should be instructed on proper inhalation technique, as efficacy is dependent on device usage. *** **Educational Disclaimer:** The drug name provided does not match any approved medication in current pharmacopeia. Information provided is for educational purposes based on likely intended agents. You must verify the drug name, current prescribing information, and local clinical protocols with your pharmacist or the product's official FDA-approved labeling before administration.